EP2958610B1 - Dispositif d'administration de médicament avec module de capture de dose dans une cartouche - Google Patents

Dispositif d'administration de médicament avec module de capture de dose dans une cartouche Download PDF

Info

Publication number
EP2958610B1
EP2958610B1 EP14705506.5A EP14705506A EP2958610B1 EP 2958610 B1 EP2958610 B1 EP 2958610B1 EP 14705506 A EP14705506 A EP 14705506A EP 2958610 B1 EP2958610 B1 EP 2958610B1
Authority
EP
European Patent Office
Prior art keywords
drug
cartridge
piston
logging unit
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14705506.5A
Other languages
German (de)
English (en)
Other versions
EP2958610A1 (fr
Inventor
John Østergaard MADSEN
Jesper Peter Windum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to EP14705506.5A priority Critical patent/EP2958610B1/fr
Publication of EP2958610A1 publication Critical patent/EP2958610A1/fr
Application granted granted Critical
Publication of EP2958610B1 publication Critical patent/EP2958610B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Definitions

  • the present invention relates to a module, device and method for capturing drug delivery dose data. Especially, the invention addresses the issue of providing an electronic data capturing system for and in a drug delivery device.
  • Drug injection devices have greatly improved the lives of patients who must self-administer drugs and biological agents.
  • Drug injection devices may take many forms, including simple disposable devices that are little more than an ampoule with an injection means or they may be durable devices adapted to be used with pre-filled cartridges. Regardless of their form and type, they have proven to be great aids in assisting patients to self-administer injectable drugs and biological agents. They also greatly assist care givers in administering injectable medicines to those incapable of performing self-injections.
  • Performing the necessary insulin injection at the right time and in the right size is essential for managing diabetes, i.e. compliance with the specified insulin regimen is important.
  • diabetes patients are encouraged to keep a log of the size and time of each injection.
  • logs are normally kept in handwritten notebooks, from the logged information may not be easily uploaded to a computer for data processing.
  • the note book system requires that the patient remembers to log each injection, if the logged information is to have any value in the treatment of the patient's disease.
  • data acquisition/monitoring functionality have been proposed to be provided in a separate device to be put on or in the injection device, i.e. some kind of accessory e.g. an add-on module to the injection device.
  • WO 2010/098927 discloses a medical module which is configured to be attached to a drug delivery pen, the module being adapted to detect and store selected and ejected dosages as well as other data. Further arrangements adapted to capture dose data are known from WO 2010/128493 , EP 2 060 284 , WO 2010/052275 and WO 2009/024562 .
  • an electronic logging unit (or module) adapted to be housed in a drug-filled cartridge outer cavity
  • the cartridge comprising a tubular main portion with a proximal opening, a distal outlet portion, and an axially displaceable piston arranged in the tubular main portion at a distance from the proximal opening, the outer cavity being formed between the piston and the proximal opening.
  • the logging unit comprises a general axis, a first distal portion adapted to engage the cartridge piston, a second proximal portion adapted to engage a rotating element having a rotational axis corresponding to the general axis, sensor means adapted to detect the amount of relative rotation between the first and second portions, and storage means adapted to store data representing detected amounts of relative rotation.
  • a logging unit can be provided in an otherwise un-modified drug delivery device comprising a piston rod rotating during dose delivery, the rotation being transferred to the proximal portion of the logging unit. This said, it may be necessary to use a cartridge with a more distally arranged piston in order to make room for the logging unit.
  • the log will typically be in the form of a number of events comprising data representing a dose amount in combination with a time value.
  • the stored data may be in the form or rotation data only, this allowing the receiving unit, e.g. a smartphone or PC, to calculate the actual drug dose amounts based on supplied information in respect of the type of drug, type of cartridge, and type of device.
  • the logging unit may be pre-programmed to work only with a given drug in a given device.
  • the stored time data may be a relative time indication which is then translated into absolute time in the receiving device.
  • the logging unit may be provided as an "ad-on" allowing a conventional durable, i.e. reusable, drug delivery device to be provided with a logging functionality when needed.
  • a conventional durable, i.e. reusable, drug delivery device may be provided with a logging functionality when needed.
  • the prescribing doctor may provide the patient with a drug delivery device in which a logging unit has been inserted, this allowing the doctor to check to which degree the patient has been in compliance with the regiment when the device is returned to the doctor after use.
  • the same logging unit could be used on a regular basis by any patient for which the logging capability and user interface are desirable.
  • the logging unit could be provided in a disposable, pre-filled device although this concept may only be cost-effective for limited use, e.g.
  • the logging unit may be provided with wireless communication, e.g. based on energy-saving passive NFC, this allowing data to be uploaded to any NFC-enabled device such as a smartphone. If the logging unit is intended to be removed from the cartridge after use also a galvanic contact could be used.
  • the logging unit comprises a first portion adapted to engage the cartridge, e.g. the piston and/or the cartridge wall, the engagement preventing rotational movement between the first portion and the cartridge during expelling of a dose of drug, and a second portion adapted to engage the piston rod, the engagement preventing rotational movement between the second portion and the piston rod during expelling of a dose of drug, wherein the first and second portions are adapted to be both moved axially corresponding to axial movement of the piston and piston rod.
  • the logging unit may be designed to be positioned between the piston and the piston rod such that the piston rod during expelling of a dose exerts a distally directed force on the logging unit, the force being transferred to the piston by the logging unit.
  • the rotation preventing engagement may be based on form and/or friction. The applied force could also be used to activate a contact to thereby turn on the unit.
  • the first portion may comprise electronic circuitry, and a first rotary sensor part, whereas the second portion may comprise a second rotary sensor part, such that the first and second parts of the rotary sensor rotate relative to each other during expelling of a dose of drug.
  • the circuitry will typically comprise a processor in the form of a microprocessor, microcontroller or CPU which may be of a general purpose design or be specifically designed for the actual device.
  • the rotary sensor may be based on any desirable technology allowing relative rotation between the two components to be detected, however, the technology should fulfil given requirements in being compact, reliable, cost-effective and energy-effective.
  • the first rotary sensor part comprises a pattern of a plurality of individual electrically conducting sensor areas connected to the electronic circuitry
  • the second rotary sensor part comprises at least one contact structure (e.g. two contact arms electrically connected to each other) adapted to engage and connect different sensor areas as the first and second part of the rotary sensor rotate relative to each, the connections being indicative of a rotational position between the first and second portions.
  • the logging unit may have an effective diameter of less than 30 mm, less than 20 mm, less than 15 mm, or less than 10 mm.
  • an electronic logging unit as described above in combination with a cartridge comprising a tubular main portion with a proximal opening, a distal outlet portion, and an axially displaceable piston arranged in the tubular main portion at a distance from the proximal opening, an outer cavity being formed between the piston and the proximal opening, wherein the logging unit is housed in the cartridge outer cavity.
  • an electronic logging unit as described above is provided in combination with a drug delivery device comprising a drug-filled cartridge and drug expelling means.
  • the drug-filled cartridge comprises a generally tubular main portion with a proximal opening, a distal outlet portion, and an axially displaceable piston arranged in the tubular main portion at a distance from the proximal opening, an outer cavity being formed between the piston and the proximal opening.
  • the drug expelling means comprising an axially displaceable piston rod adapted to move the piston of a cartridge in a distal direction to thereby expel drug from the cartridge, the piston rod rotating relative to the cartridge during axial movement.
  • the electronic logging unit is initially arranged at least partly in the cartridge outer cavity and being configured to be moved fully there into, the sensor means being adapted to detect the amount of relative rotation between the piston rod and the cartridge during expelling of a dose of drug, the amount of relative rotation corresponding to the dose amount of drug expelled, the storage means adapted to store data representing expelled dose amounts.
  • engagement of the first portion and the cartridge prevents rotational movement there between during expelling of a dose of drug
  • engagement of the second portion and the piston rod prevents rotational movement there between during expelling of a dose of drug, the first and second portion being adapted to be moved axially corresponding to axial movement of the piston and piston rod.
  • the distally directed force on the logging unit may be transferred to the piston by the logging unit.
  • a method for providing a drug delivery device adapted to create a log for expelled amounts of a drug comprising the steps of providing (i) a drug-filled cartridge comprising a generally tubular main portion with a proximal opening, a distal outlet portion, and an axially displaceable piston arranged in the tubular main portion at a distance from the proximal opening, an outer cavity being formed between the piston and the proximal opening, (ii) a drug delivery device adapted to receive the drug-filled cartridge, comprising drug expelling means comprising dose setting means allowing a user to set a dose of drug to be expelled from a received drug-filled cartridge, and an axially displaceable piston rod adapted to move the piston of a received drug-filled cartridge in a distal direction to thereby expel drug from the cartridge, the piston rod rotating relative to the cartridge during axial movement, and (iii) an electronic logging unit adapted to be arranged initially at least partly in
  • the method comprises the further step of (iv) arranging the drug-filled cartridge and the logging unit in the drug delivery device, the logging unit being arranged at least partly in the cartridge outer cavity.
  • the provided logging unit may comprise a first portion adapted to engage the piston, the engagement preventing rotational movement between the first portion and the piston during expelling of a dose of drug, and a second portion adapted to engage the piston rod, the engagement preventing rotational movement between the second portion and the piston rod during expelling of a dose of drug, wherein the first and second portions are adapted to be moved axially corresponding to the axial movement of the piston and piston rod.
  • drug is meant to encompass any flowable medicine formulation capable of being passed through a delivery means such as a cannula or hollow needle in a controlled manner, such as a liquid, solution, gel or fine suspension, and containing one or more drug agents.
  • the drug may be a single drug compound or a premixed or co-formulated multiple drug compounds drug agent from a single reservoir.
  • Representative drugs include pharmaceuticals such as peptides (e.g. insulins, insulin containing drugs, GLP-1 containing drugs as well as derivatives thereof), proteins, and hormones, biologically derived or active agents, hormonal and gene based agents, nutritional formulas and other substances in both solid (dispensed) or liquid form.
  • peptides e.g. insulins, insulin containing drugs, GLP-1 containing drugs as well as derivatives thereof
  • proteins e.g. insulins, insulin containing drugs, GLP-1 containing drugs as well as derivatives thereof
  • hormones e.g. insulins, insulin containing drugs, GLP-1 containing drugs as well as
  • the device represents a "generic" drug delivery device providing an example of a device in combination with which embodiments of the present invention is intended to be used, such a device comprising a piston rod which rotates during expelling of a dose of drug.
  • the pen device comprises a cap part (not shown) and a main part having a proximal body or drive assembly portion with a housing 120 in which a drug expelling mechanism is arranged or integrated, and a distal cartridge holder portion in which a drug-filled transparent cartridge 180 with a distal needle-penetrable septum 187 can be arranged and retained in place by a cartridge holder 110 attached to the proximal portion, the cartridge holder having openings allowing a portion of the cartridge to be inspected.
  • the cartridge may for example contain an insulin, GLP-1 or growth hormone formulation.
  • the device is designed to be loaded by the user with a new cartridge through a distal receiving opening in the cartridge holder, the cartridge being provided with a piston driven by a piston rod 128 forming part of the expelling mechanism.
  • a proximal-most rotatable dose ring member 125 serves to manually set a desired dose of drug shown in display window 126 and which can then be expelled when the release button 127 is actuated.
  • the expelling mechanism may comprise a spring which is strained during dose setting and then released to drive the piston rod when the release button is actuated.
  • the expelling mechanism may be fully manual in which case the dose ring member and the release button moves proximally during dose setting corresponding to the set dose size, and then moved distally by the user to expel the set dose.
  • the cartridge is provided with distal coupling means in the form of a needle hub mount 182 having, in the shown example, an external thread 185 adapted to engage an inner thread of a corresponding hub of a needle assembly.
  • the thread may be combined with or replaced by other connection means, e.g. a bayonet coupling.
  • the shown exemplary hub mount further comprises a circumferential flange 186 with a number of distally facing projections 189 serving as a coupling means for the cartridge holder as will be described in detail below.
  • a hub mount of the shown type is described in US 5,693,027 .
  • the cartridge holder is adapted to receive and hold the cartridge in a loaded position, the holder having a generally tubular configuration with a distal opening adapted to axially receive the cartridge in a proximal direction, the holder and the cartridge being provided with corresponding coupling means allowing a cartridge to be mounted and subsequently released.
  • the shown embodiment comprises a main cartridge holder portion 130 on which an axially sliding locking member 140 is arranged, the locking member comprising two opposed arms 144 each having distal gripping means 149 adapted for engagement with the cartridge flange 186.
  • An example of an expelling mechanism allowing a user to set a desired dose as well as comprising a cartridge actuated coupling allowing the piston rod to be pushed back by a cartridge during loading is disclosed in e.g. US 2004/0210199 .
  • Fig. 2 shows the cartridge 180 mounted in the cartridge holder 110.
  • fig. 1 shows a drug delivery device of the front-loaded type in which a cartridge is inserted through a distal opening in the cartridge holder which in non-removable attached to the main part of the device, however, presently the most common type of non-disposable drug delivery device on the market comprises a cartridge holder adapted to be removed from the device main portion and in which a cartridge is received and removed through the proximal opening.
  • the logging unit of the present invention in one configuration is intended to be used in combination with existing types of drug delivery devices, it may be necessary to modify the design of the piston engaging part of the piston rod. More specifically, most existing piston rods of the type which rotates during expelling of a dose comprise a distal piston-engaging foot or washer allowing the piston rod to freely rotate during out-dosing.
  • a modified piston rod foot should allow a piston rod engaging structure on the logging unit to engage the piston rod non-rotationally, e.g. through a central opening in the piston rod foot. Under standard use conditions the piston rod foot should ensure non-rotational engagement with the elastomeric piston and be freely rotational relative to the piston rod. If the logging unit is supplied as part of a disposable delivery device the piston rod may comprise no foot.
  • the drug-filled cartridge 200 comprises a generally tubular main portion 201 with a proximal opening 202, a distal outlet portion (see fig. 1 ), and an axially displaceable elastomeric piston 203 arranged in the tubular main portion at a distance from the proximal opening, an outer cavity 204 being formed between the piston and the proximal opening.
  • the cartridge is arranged in a drug delivery device (not shown) comprising drug expelling means having an axially displaceable piston rod 210 with a foot 211 adapted to move the piston of the cartridge in a distal direction to thereby expel drug from the cartridge, the piston rod rotating relative to the cartridge during axial movement.
  • An electronic logging unit 220 is arranged in the cartridge outer cavity and is configured to be moved further distally together with the piston by the piston rod.
  • the logging unit comprises a sealed and essentially closed housing in which sensor means adapted to detect the amount of relative rotation between the piston rod and the cartridge during expelling of a dose of drug is arranged, the detected amount of relative rotation corresponding to the dose amount of drug expelled.
  • the housing 221 has a generally cylindrical configuration with an outer diameter slightly smaller than the inner diameter of the cartridge in combination with which the logging unit is intended to be used.
  • the circumferential portion of the housing may be provided with elastic means engaging the cartridge inner wall, e.g. flexible fingers (not shown), preventing the unit from rattling. If the logging unit is intended to be placed in and removed from the cartridge manually such flexible fingers should support safe and easy operation.
  • the housing comprises a generally planar distal surface 222 adapted to non-rotationally engage the piston proximal surface, e.g. by means of friction or a number of projections, e.g. spikes. If the logging unit is not intended to be removed from the cartridge after use it may be supplied permanently attached to the piston.
  • the opposed proximal housing surface 223 is also substantially planar and is provided with a piston rod engaging member 224 rotationally mounted to the housing.
  • the piston rod engaging member is designed to engage the distal portion of a given piston rod in a non-rotational engagement.
  • a first stationary portion 225 comprising electronic circuitry 226, a battery 227 and a first rotary sensor part 228.
  • the electronic circuitry will typically comprise a micro controller, memory and, in the shown embodiment, means for wireless upload of stored data, e.g. by means of NFC.
  • a second rotary sensor part 229 is non-rotationally mounted relative to the rotatable piston rod engaging member.
  • the rotary sensor comprises a first stationary rotary sensor part comprising a surface with a plurality of individual electrically conducting sensor areas arranged in a pattern and connected to the electronic circuitry, and a second rotary sensor part arranged rotationally relative to the first portion, the second rotary sensor part comprising a plurality of contacts electrically connected to each other and adapted to be in contact with conducting sensor areas on the first sensor rotary part.
  • the sensor areas and the contacts are configured to create a pattern of contact positions indicative of a rotational position between the first and second portions, the electronic circuitry being adapted to detect changes and/or positions of the rotary sensor parts relative to each other.
  • the code pattern may have a "resolution" of e.g.
  • 15 degrees of rotations which for a given drug formulation and delivery device combination may correspond to 1 unit (IU) of insulin.
  • the amount of rotation can be detected using a number of designs, e.g. each increment may be counted, or a given position may be detected absolutely within sectors of e.g. 120 or 360 degrees, a counter registering the number of completed sectors.
  • the logging unit may be provided with a contact allowing it to be switched on when used for the first time.
  • the piston rod engaging member may be arranged to have an initial axial position and an actuated in which it is pushed distally when pressurized by the piston rod for the first time, this actuating a contact in the interior of the housing, e.g. formed integrally with the rotary sensor as shown in fig. 5 .
  • the logging unit may be programmed to log two dose amounts expelled within a given time window, e.g. 5 minutes, as one dose.
  • the stored data may be in the form or rotation data only, this allowing the receiving unit, e.g. a smartphone or PC, to calculate the actual drug dose amounts based on supplied information in respect of the type of drug, type of cartridge, and type of device.
  • the logging unit may be pre-programmed to work only with a given drug in a given device, this especially being the case when the logging unit is supplied as part of a cartridge or as part of a pre-filled drug delivery device.
  • Figs. 4 and 5 show an exemplary embodiment of a pair of rotary sensor parts of the above-described type having a stationary sensor part comprising a surface with a plurality of individual electrically conducting sensor areas arranged in a pattern, and a second rotary sensor part comprising a number of flexible contact arms electrically connected to each other and adapted to be in contact with the corresponding conducting sensor areas on the first sensor rotary part.
  • the shown embodiment further comprises axially actuated switch arms.
  • fig. 4 shows the first rotary sensor part 320 comprising a ring-formed disc formed from circuit board material and on which a number of contact areas 322 has been plated on forming three concentric rings, an inner, an intermediate and an outer ring.
  • the inner ring is a single contact area used as ground
  • the intermediate and outer rings comprise a number of discrete arch-formed contact area segments, at least a portion of the segments being individually connected terminals of to the electronic circuitry mounted on the rear (distal) face of the disc. If a given segment is not connected to a terminal it can be considered a passive segment.
  • each contact arm is in the form of a metallic disc comprising a number of flexible arcformed contact arms 332 protruding proximally (although the entire disc appears to be planar in the figure), the distal end of each contact arm comprising a contact point 333 adapted to create a galvanic connection with a given contact area.
  • a given pair of contact arms provides a contact structure adapted to create electric contact between two contact areas.
  • one contact arm is provided to be in contact with the single contact area of the inner concentric ring, three contacts arms are provided to be in contact with the contact areas of the intermediate concentric ring, and two outer switch contact arms 334 are provided to be in contact with the contact areas of the outer concentric ring, the outer contact arms carrying a laterally extending projection 331.
  • the switch contacts are used to turn on the electronics when the module is used for the first time.
  • the inner and intermediate arms and contact areas provide the rotary sensor contacts whereas the outer arms and contact areas provide an axial switch.
  • the two outer arms 334 are in the shown embodiment used to provide redundancy for the axial switch, however, in cooperation with the contact areas of the outer ring they could additionally be used to provide rotational information.
  • the electrically connected arms create a number of "on" galvanic contacts between given pairs of contact areas, other non-connected areas representing an "off" contact condition.
  • the shown rotary sensor has a resolution of 15 degrees such that for each 15 degrees of rotation a pre-determined change in which of the individual rotary contacts are on and off is created.
  • the code pattern has a step "resolution" of 15 degrees of rotations which for a given drug formulation and delivery device combination may correspond to 1 unit (IU) of insulin.
  • IU unit
  • the rotary sensor comprising the rotary contacts and the associated electronic circuitry could be designed to detect the amount of rotation using a number of designs, e.g. each 15 degrees increment may be counted, or a given position may be detected absolutely within sectors of e.g. 120 or 360 degrees, a counter registering the number of completed sectors.
  • a counter could be implemented using the switch arms and outer contact areas described with reference to figs. 4 and 5 .
  • the rotary sensor is designed to count the number of steps during expelling, with the expelling steps being registered in the log as the dose being expelled.
  • the logging module may be programmed to log two dose amounts expelled within a given time window, e.g. 15 minutes, as one dose.
  • Fig. 6 shows a drug delivery pen 400 comprising a dose setting member 425 and being provided with a cartridge-mounted logging module as described above, the pen being arranged next to a smartphone 430 configured to receive logging data from the logging module via wireless communication, e.g. NFC.
  • wireless communication e.g. NFC.
  • the smartphone In order to communicate with the logging module the smartphone has been provided with specific "insulin diary" software.
  • the smartphone NFC transmitter When the software is activated to initiate data transfer the smartphone NFC transmitter will transmit specific code which will wake up any nearby logging module which will then retransmit a unique code identifying the specific module.
  • the module may transmit information in respect of the drug in the cartridge, e.g. "Mix 30" as shown. In this way the smartphone can create an insulin diary indicate the specific drug.
  • log data from a logging module associated with a Mix 30 insulin has been transferred.
  • the user can toggle back and forth between different day views, each day view showing the different amounts of drug delivered together with a real time value.
  • first and second amounts 432 of Mix 30 has been delivered with the time and amount shown for each delivery.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Claims (11)

  1. Unité-témoin électronique (220), comprenant :
    - un axe général,
    - une première partie distale (221),
    - une seconde partie proximale (224),
    - des moyens de captage (225, 228, 229) aptes à détecter la quantité de rotation relative entre les première et seconde parties, et
    - un moyen de stockage (225) apte à stocker des données représentant les quantités détectées de rotation relative,
    caractérisée en ce que l'unité-témoin électronique est apte à être logée dans une cavité extérieure (204) d'une cartouche (200) remplie de médicament, la cartouche comprenant une partie principale tubulaire ayant une ouverture proximale, une partie de sortie distale et un piston (203) pouvant se déplacer axialement, disposé dans la partie principale tubulaire à une certaine distance de l'ouverture proximale, la cavité extérieure étant constituée entre le piston et l'ouverture proximale,
    dans laquelle :
    - la première partie distale (221) est apte à entrer en prise avec le piston de la cartouche, et
    - la seconde partie proximale (224) est apte à entrer en prise avec un élément rotatif ayant un axe de rotation correspondant à l'axe général.
  2. Unité-témoin électronique selon la revendication 1,
    dans laquelle la première partie comprend :
    - des circuits électroniques (226), et
    - une première pièce (228, 320) du capteur de rotation,
    dans laquelle la seconde partie comprend :
    - une seconde pièce (229, 330) du capteur de rotation.
  3. Unité-témoin électronique selon la revendication 2, dans laquelle :
    (i) la première pièce du capteur de rotation comprend une disposition d'une pluralité de zones individuelles (322) de capteur conductrices électriques, raccordées aux circuits électroniques, et
    (ii) la seconde pièce du capteur de rotation comprend au moins une structure de contact (332) apte à venir au contact des différentes zones de capteur et les raccorder lorsque la première et la seconde pièce du capteur de rotation tournent l'une par rapport à l'autre, les connexions indiquant une position de rotation entre les première et seconde pièces.
  4. Unité-témoin électronique selon l'une quelconque des revendications 1 à 3, dans laquelle l'unité-témoin électronique comprend en outre un moyen d'émetteur apte à transmettre des données stockées à un récepteur externe.
  5. Unité-témoin électronique selon l'une quelconque des revendications 1 à 4, dans laquelle l'unité-témoin a un diamètre effectif de moins de 30 mm.
  6. Unité-témoin électronique selon l'une quelconque des revendications 1 à 5 combinée avec une cartouche comprenant une partie principale tubulaire ayant une ouverture proximale, une partie de sortie distale et un piston pouvant se déplacer axialement, disposé dans la partie principale tubulaire à une certaine distance de l'ouverture proximale, une cavité extérieure (204) étant constituée entre le piston et l'ouverture proximale,
    - l'unité-témoin étant logée dans la cavité extérieure de la cartouche.
  7. Unité-témoin électronique selon l'une quelconque des revendications 1 à 5 combinée avec un dispositif (100) d'administration de médicament comprenant :
    - une cartouche (180, 200) remplie de médicament comprenant :
    une partie principale dans l'ensemble tubulaire ayant une ouverture proximale (202),
    une partie de sortie distale et
    un piston (203) pouvant se déplacer axialement, disposé dans la partie principale tubulaire à une certaine distance de l'ouverture proximale, une cavité extérieure (204) étant constituée entre le piston et l'ouverture proximale,
    - un moyen d'expulsion du médicament comprenant une tige (128, 210) de piston pouvant se déplacer axialement et apte à déplacer le piston d'une cartouche dans la direction distale pour de ce fait expulser le médicament de la cartouche, la tige de piston tournant par rapport à la cartouche pendant le mouvement axial,
    l'unité-témoin électronique (220) étant au départ disposée au moins partiellement dans la cavité extérieure de la cartouche et étant configurée pour y être entrée entièrement, les moyens de captage (225, 228, 229) étant aptes à détecter la quantité de rotation relative entre la tige de piston et la cartouche pendant l'expulsion d'une dose de médicament, la quantité de rotation relative correspondant à la quantité de dose de médicament expulsé, le moyen de stockage (225) étant apte à stocker des données représentant les quantités de dose expulsées.
  8. Unité-témoin électronique combinée avec un dispositif d'administration de médicament selon la revendication 7,
    - dans laquelle l'enclenchement de la première partie et de la cartouche empêche un mouvement de rotation entre elles pendant l'expulsion d'une dose de médicament, et l'enclenchement de la seconde partie (224) et de la tige (210) de piston empêche un mouvement de rotation entre elles pendant l'expulsion d'une dose de médicament, et
    - dans laquelle la première et la seconde partie sont aptes à être déplacées axialement en liaison avec un mouvement axial du piston et la tige de piston.
  9. Unité-témoin électronique combinée avec un dispositif d'administration de médicament selon la revendication 7 ou 8, dans laquelle la tige de piston, pendant l'expulsion d'une dose, exerce une force en direction distale sur l'unité-témoin, la force étant transférée au piston par l'unité-témoin.
  10. Procédé pour fournir un dispositif d'administration de médicament apte à créer un journal pour les quantités expulsées d'un médicament, comprenant les étapes consistant à :
    (i) procurer une cartouche remplie de médicament comprenant :
    - une partie principale dans l'ensemble tubulaire ayant une ouverture proximale,
    - une partie de sortie distale et
    - un piston pouvant se déplacer axialement, disposé dans la partie principale tubulaire à une certaine distance de l'ouverture proximale, une cavité extérieure étant constituée entre le piston et l'ouverture proximale,
    (ii) procurer un dispositif d'administration de médicament apte à recevoir la cartouche remplie de médicament, comprenant un moyen d'expulsion de médicament comprenant :
    - un moyen de réglage de dose permettant à un utilisateur de fixer une dose de médicament à expulser d'une cartouche reçue remplie de médicament,
    - une tige de piston pouvant se déplacer axialement et apte à déplacer le piston d'une cartouche reçue remplie de médicament dans la direction distale pour de ce fait expulser le médicament de la cartouche, la tige de piston tournant par rapport à la cartouche pendant le mouvement axial,
    (iii) procurer une unité-témoin électronique selon l'une quelconque des revendications 1 à 9, apte à être au départ disposée au moins partiellement dans la cavité extérieure de la cartouche et étant configurée pour y être entrée entièrement, l'unité-témoin comprenant :
    - des moyens de captage aptes à détecter la quantité de rotation relative entre la tige de piston et la cartouche pendant l'expulsion d'une dose de médicament, la quantité de rotation relative correspondant à la quantité de dose de médicament expulsé, et
    - un moyen de stockage apte à stocker des données représentant les quantités de dose expulsées,
    (iv) disposer la cartouche remplie de médicament et l'unité-témoin dans le dispositif d'administration de médicament, l'unité-témoin étant disposée au moins partiellement dans la cavité extérieure de la cartouche.
  11. Procédé selon la revendication 10, dans lequel l'unité-témoin fournie comprend :
    - une première partie apte à entrer en prise avec le piston, l'enclenchement empêchant un mouvement de rotation entre la première partie et le piston pendant l'expulsion d'une dose de médicament, et
    - une seconde partie apte à entrer en prise avec la tige de piston, l'enclenchement empêchant un mouvement de rotation entre la seconde partie et la tige de piston pendant l'expulsion d'une dose de médicament,
    dans laquelle les première et seconde parties sont aptes à être déplacées axialement en liaison avec le mouvement axial du piston et la tige de piston.
EP14705506.5A 2013-02-19 2014-02-19 Dispositif d'administration de médicament avec module de capture de dose dans une cartouche Active EP2958610B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14705506.5A EP2958610B1 (fr) 2013-02-19 2014-02-19 Dispositif d'administration de médicament avec module de capture de dose dans une cartouche

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP13155800 2013-02-19
US201361767820P 2013-02-22 2013-02-22
PCT/EP2014/053219 WO2014128155A1 (fr) 2013-02-19 2014-02-19 Module de cartouche de capture de dose pour dispositif d'administration de médicament
EP14705506.5A EP2958610B1 (fr) 2013-02-19 2014-02-19 Dispositif d'administration de médicament avec module de capture de dose dans une cartouche

Publications (2)

Publication Number Publication Date
EP2958610A1 EP2958610A1 (fr) 2015-12-30
EP2958610B1 true EP2958610B1 (fr) 2016-11-30

Family

ID=47715930

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14705506.5A Active EP2958610B1 (fr) 2013-02-19 2014-02-19 Dispositif d'administration de médicament avec module de capture de dose dans une cartouche

Country Status (5)

Country Link
US (1) US10201664B2 (fr)
EP (1) EP2958610B1 (fr)
JP (1) JP6336490B2 (fr)
CN (1) CN105007964B (fr)
WO (1) WO2014128155A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722654B2 (en) 2014-02-18 2020-07-28 Owen Mumford Limited Injection device

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2958612B1 (fr) 2013-02-19 2018-04-11 Novo Nordisk A/S Dispositif d'administration de médicament avec module de capture de dose
WO2014128156A1 (fr) 2013-02-19 2014-08-28 Novo Nordisk A/S Module capteur rotatif à commutateur axial
WO2015075135A1 (fr) 2013-11-21 2015-05-28 Novo Nordisk A/S Module de capteur rotatif avec caractéristique de resynchronisation
WO2015075136A1 (fr) 2013-11-21 2015-05-28 Novo Nordisk A/S Ensemble capteur rotatif avec commutateur axial et élément de redondance
US11311678B2 (en) 2013-11-21 2022-04-26 Novo Nordisk A/S Rotary sensor assembly with space efficient design
WO2016138634A1 (fr) 2015-03-03 2016-09-09 创新精密仪器有限公司 Appareil de surveillance d'informations de médicament et appareil du type à injection de surveillance d'informations de médicament
CN108472454B (zh) * 2015-12-28 2020-12-08 诺和诺德股份有限公司 具有低功率特征的旋转传感器组件
EP4338772A3 (fr) 2016-02-26 2024-05-15 Eli Lilly and Company Dispositif d'administration de médicament réutilisable avec capacité de détermination de médicament restant
AU2017237925B2 (en) 2016-03-25 2019-04-04 Eli Lilly And Company Determination of a dose set and delivered in a medication delivery device
WO2017174588A1 (fr) * 2016-04-05 2017-10-12 Chiesi Farmaceutici S.P.A. Procédé de comptage de doses de médicament distribuées par un inhalateur
US11266788B2 (en) 2016-04-19 2022-03-08 Eli Lilly And Company Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor
WO2018002314A1 (fr) * 2016-07-01 2018-01-04 Sanofi Dispositif d'administration de médicament
CN113694314B (zh) 2016-07-15 2023-09-05 伊莱利利公司 用于药物输送装置的剂量检测模块
US9636464B1 (en) * 2016-08-01 2017-05-02 Innovative Precision Instruments Limited Drug delivery device and a drug information detection device
JP6718554B2 (ja) 2016-08-12 2020-07-08 イーライ リリー アンド カンパニー 薬剤送達デバイスにおける用量の判定
CN107789706B (zh) * 2016-09-06 2021-12-03 广东东阳光药业有限公司 注射器用数据采集方法、采集结构、注射器及注射系统
JP6828165B2 (ja) 2016-12-15 2021-02-10 イーライ リリー アンド カンパニー 感知システムを備えた薬剤送達デバイス
JP7018449B2 (ja) * 2017-02-01 2022-02-10 ノボ・ノルデイスク・エー／エス 使い捨てペン式薬剤送達装置用およびその内部の回転式用量センシングモジュール
CN110769881A (zh) * 2017-05-05 2020-02-07 赛诺菲 具有分布式电子部件的药筒
EP4285966A3 (fr) 2017-05-05 2024-02-14 Sanofi Accouplement électrique pour dispositifs d'injection
WO2019012475A2 (fr) 2017-07-12 2019-01-17 Insuline Medical Ltd. Dispositif de suivi de médicament
EP3672668A1 (fr) 2017-08-21 2020-07-01 Eli Lilly and Company Dispositif d'administration de médicament doté d'un système de détection
JP6932836B2 (ja) 2017-08-21 2021-09-08 イーライ リリー アンド カンパニー 薬物送達装置のための用量検出モジュール
CN111132713A (zh) 2017-09-30 2020-05-08 诺和诺德股份有限公司 用于药物输送装置的药筒系统
JP7408545B2 (ja) 2017-11-14 2024-01-05 サノフイ 注射デバイスのプランジャストッパ内への超音波センサの組み込み
CN117065149A (zh) 2017-11-23 2023-11-17 赛诺菲 具有旋转编码器的药剂注射装置
WO2019170828A1 (fr) 2018-03-09 2019-09-12 Novo Nordisk A/S Protocole de transmission pour dispositif médical avec caractéristique de journalisation
CN111971753A (zh) 2018-04-03 2020-11-20 诺和诺德股份有限公司 数据传输安全特征
US20210283339A1 (en) 2018-07-10 2021-09-16 Novo Nordisk A/S A rotary dosage sensing module for a disposable drug delivery pen and a method of assembling the same
CN114555157A (zh) 2019-10-08 2022-05-27 诺和诺德股份有限公司 具有摩擦增强装置的剂量感测模块
CN114901332A (zh) 2019-12-18 2022-08-12 诺和诺德股份有限公司 固定剂量注射装置
JP2023506830A (ja) 2019-12-18 2023-02-20 ノボ・ノルデイスク・エー／エス 所定の固定用量を送達するための薬剤送達装置
EP4076599A1 (fr) 2019-12-18 2022-10-26 Novo Nordisk A/S Dispositif d'injection de dose fixe
US20230001101A1 (en) 2019-12-18 2023-01-05 Novo Nordisk A/S Fixed dose injection device
WO2021213912A1 (fr) 2020-04-23 2021-10-28 Novo Nordisk A/S Dispositif de distribution de médicament activable doté d'un ensemble de sécurité
US20230191037A1 (en) 2020-05-18 2023-06-22 Novo Nordisk A/S Drug delivery device with click sound during delivery
US20240307631A1 (en) 2021-02-18 2024-09-19 Novo Nordisk As Drug delivery device for delivering a predefined fixed dose
WO2022175242A1 (fr) 2021-02-18 2022-08-25 Novo Nordisk A/S Dispositif d'administration de médicament pour l'administration d'une dose fixe prédéfinie
WO2022175246A1 (fr) 2021-02-18 2022-08-25 Novo Nordisk A/S Dispositif d'administration de médicament pour l'administration d'une dose fixe prédéfinie

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4854324A (en) 1984-01-31 1989-08-08 Medrad, Inc. Processor-controlled angiographic injector device
US4807248A (en) 1984-05-23 1989-02-21 Rockwell International Corporation Automatic resynchronization technique
US4891476A (en) 1988-05-09 1990-01-02 Illinois Tool Works, Inc. Index rotary switch
DK0549694T3 (da) 1990-09-21 1995-10-16 Novo Nordisk As Adaptertop
DE59202070D1 (de) 1991-07-24 1995-06-08 Medico Dev Investment Co Injektor.
US5315077A (en) 1993-04-05 1994-05-24 Bourns, Inc. Rotary switch including cam operated flexible contacts
EP0623942A1 (fr) 1993-04-20 1994-11-09 FRITZ HARTMANN GERÄTEBAU GMBH & CO KG Codeur
US5739775A (en) 1993-07-22 1998-04-14 Bourns, Inc. Digital input and control device
US6110148A (en) * 1994-07-22 2000-08-29 Health Hero Network, Inc. Capacitance-based dose measurements in syringes
US5628309A (en) * 1996-01-25 1997-05-13 Raya Systems, Inc. Meter for electrically measuring and recording injection syringe doses
JP3677877B2 (ja) 1996-07-25 2005-08-03 松下電器産業株式会社 ゲーム機用エンコーダ
JP3763169B2 (ja) 1996-08-23 2006-04-05 松下電器産業株式会社 プッシュスイッチ付き回転操作型電子部品およびその製造方法
FR2796755B1 (fr) 1999-07-21 2001-09-07 Itt Mfg Enterprises Inc Commutateur electrique a organe unique d'actionnement rotatif et axial
US6277099B1 (en) * 1999-08-06 2001-08-21 Becton, Dickinson And Company Medication delivery pen
US6585698B1 (en) * 1999-11-01 2003-07-01 Becton, Dickinson & Company Electronic medical delivery pen having a multifunction actuator
JP4278382B2 (ja) 2001-02-14 2009-06-10 ノボ ノルディスク アクティーゼルスカブ 電子制御される注射器即ち注入装置
ATE355093T1 (de) * 2001-05-16 2006-03-15 Lilly Co Eli Arzneimitteleinspritzvorrichtung mit rückstellung erleichternder antriebsanordnung
DE10133216B4 (de) 2001-07-09 2005-01-27 Tecpharma Licensing Ag Positionsdetektion
FR2837926B1 (fr) 2002-03-27 2004-05-28 Siemens Vdo Automotive Procede de fabrication d'un capteur de vitesse d'une roue et capteur correspondant
DE10330985A1 (de) 2003-07-09 2005-02-17 Tecpharma Licensing Ag Vorrichtung zur Verabreichung eines fluiden Produkts mit optischer Abtastung
EP1827537B1 (fr) 2004-10-21 2019-08-14 Novo Nordisk A/S Dispositif de délivrance d'un médicament avec un détecteur délivrant un signal indicatif d'une dose éjectée.
JP5147407B2 (ja) * 2004-10-21 2013-02-20 ノボ・ノルデイスク・エー／エス 放出情報を収集するプロセッサを備えた注入装置
DE102004063664A1 (de) 2004-12-31 2006-07-20 Tecpharma Licensing Ag Echtzeitanzeige für eine Vorrichtung zur dosierten Verabreichung eines Produkts
EP1881859B1 (fr) 2005-05-10 2011-01-19 Novo Nordisk A/S Dispositif d'injection comprenant un capteur optique
HUE053543T2 (hu) * 2006-09-15 2021-07-28 Ypsomed Ag Injektálókészülék javított szállítóelemmel
EP2073871B1 (fr) 2006-09-29 2013-03-20 Novo Nordisk A/S Dispositif d'injection comportant un moyen de détection électronique
US20080135094A1 (en) 2006-12-11 2008-06-12 Sunmodular, Inc. Photovoltaic roof tiles and methods of making same
JP4315983B2 (ja) 2007-01-19 2009-08-19 ホシデン株式会社 複合スイッチ
EP2125075A2 (fr) 2007-01-22 2009-12-02 Intelliject, Inc. Injecteur médical équipé d'un système de détection et de surveillance de l'observance
US20080243088A1 (en) * 2007-03-28 2008-10-02 Docusys, Inc. Radio frequency identification drug delivery device and monitoring system
IL183471A0 (en) 2007-05-28 2007-09-20 Yaskawa Europ Technology Ltd Absolute encoder
EP2190506B1 (fr) 2007-08-17 2011-08-17 Novo Nordisk A/S Dispositif médical avec capteur de valeur
EP2060284A1 (fr) 2007-11-13 2009-05-20 F.Hoffmann-La Roche Ag Dispositif d'injection médical avec moyen d'entrée de données et écran pivotant
ES2385630T3 (es) * 2007-12-31 2012-07-27 Novo Nordisk A/S Dispositivo de inyección controlado electrónicamente
GB0800538D0 (en) 2008-01-11 2008-02-20 Crompton Technology Group Ltd Fuel pipes with controlled resistivity
ES2713177T3 (es) 2008-10-28 2019-05-20 Hoffmann La Roche Un procedimiento para supervisar la operación de un dispositivo de administración de medicamentos, un módulo electrónico y un sistema de administración de medicamentos
WO2010052275A2 (fr) 2008-11-06 2010-05-14 Novo Nordisk A/S Dispositif électroniquement assisté d'administration de médicament
WO2010088973A1 (fr) 2009-02-06 2010-08-12 Shl Group Ab Dispositif d'administration de médicament avec détecteur électronique de dose
DE102009008457A1 (de) 2009-02-11 2010-08-12 Continental Automotive Gmbh Verfahren zur Herstellung eines Sensors mit nahtloser Umspritzung eines Sensorelementes
CA2753069C (fr) 2009-02-27 2017-11-21 Lifescan, Inc. Systeme de distribution de medicaments
US20100286612A1 (en) * 2009-05-06 2010-11-11 William Cirillo Medication injection supervisor device
US20110025311A1 (en) 2009-07-29 2011-02-03 Logitech Europe S.A. Magnetic rotary system for input devices
DE102009048497A1 (de) 2009-09-26 2011-03-31 Haselmeier Gmbh Injektionsgerät
EP2483942B8 (fr) 2009-09-29 2014-04-02 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Procédé de fabrication d'un module fonctionnel piézoélectrique
EP2327431A1 (fr) 2009-11-25 2011-06-01 Letcat Aktiebolag Dispositif d'administration médicale
CN201692426U (zh) * 2010-04-23 2011-01-05 深圳市利泰尔科技有限公司 配置伺服机构的胰岛素泵
EP2696918A2 (fr) 2011-04-11 2014-02-19 Novo Nordisk A/S Dispositif d'injection incorporant une surveillance de dose
US9623188B2 (en) * 2011-07-07 2017-04-18 Novo Nordisk A/S Drug delivery injection pen with add-on dose capturing and display module
CN105771039B (zh) 2011-07-15 2020-01-10 赛诺菲-安万特德国有限公司 药物输送装置
US9192728B2 (en) * 2011-07-15 2015-11-24 Sanofi-Aventis Deutschland Gmbh Drug delivery device
US10155090B2 (en) * 2011-10-07 2018-12-18 Novo Nordisk A/S System for determining position of an element in relation to another element using magnetic fields
EP2788047A1 (fr) 2011-12-06 2014-10-15 Novo Nordisk A/S Mécanisme d'entraînement pour un dispositif d'injection et procédé d'assemblage d'un dispositif d'injection incorporant un tel mécanisme d'entraînement
WO2013098421A1 (fr) 2011-12-30 2013-07-04 Novo Nordisk A/S Dispositif d'injection à usage médical intégrant un dispositif de détection de la dose et procédé de production d'un tel détecteur de dose
US9212935B2 (en) 2012-10-30 2015-12-15 Panasonic Intellectual Property Management Co., Ltd. Rotary encoder
WO2014128156A1 (fr) 2013-02-19 2014-08-28 Novo Nordisk A/S Module capteur rotatif à commutateur axial
EP2958612B1 (fr) * 2013-02-19 2018-04-11 Novo Nordisk A/S Dispositif d'administration de médicament avec module de capture de dose
US20140276583A1 (en) * 2013-03-15 2014-09-18 Bayer Healthcare Llc Injection device with automatic data capture and transmission
WO2015075135A1 (fr) 2013-11-21 2015-05-28 Novo Nordisk A/S Module de capteur rotatif avec caractéristique de resynchronisation
WO2015075136A1 (fr) * 2013-11-21 2015-05-28 Novo Nordisk A/S Ensemble capteur rotatif avec commutateur axial et élément de redondance
US11311678B2 (en) 2013-11-21 2022-04-26 Novo Nordisk A/S Rotary sensor assembly with space efficient design
JP6716566B2 (ja) 2014-12-19 2020-07-01 アムジエン・インコーポレーテツド 近接センサ付き薬物送達装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722654B2 (en) 2014-02-18 2020-07-28 Owen Mumford Limited Injection device

Also Published As

Publication number Publication date
WO2014128155A1 (fr) 2014-08-28
JP2016510241A (ja) 2016-04-07
EP2958610A1 (fr) 2015-12-30
JP6336490B2 (ja) 2018-06-06
CN105007964B (zh) 2018-01-30
US20160008552A1 (en) 2016-01-14
CN105007964A (zh) 2015-10-28
US10201664B2 (en) 2019-02-12

Similar Documents

Publication Publication Date Title
EP2958610B1 (fr) Dispositif d'administration de médicament avec module de capture de dose dans une cartouche
EP2958611B1 (fr) Module de capteur rotatif avec commutation axiale
US9750886B2 (en) Drug delivery device with dose capturing module
CN107073220B (zh) 具有在夹子构件上的电子显示器的笔型药物输送装置
EP3071262B1 (fr) Ensemble de capteur rotatif pourvu d'une conception efficace au niveau de l'espace
EP3071259B1 (fr) Ensemble de capteur rotatif avec caractéristique de redondance et de commutation axiale
EP2981312B1 (fr) Système d'administration de médicament avec un moyen de journalisation conçu pour combiner des doses
US11083853B2 (en) Rotary sensor assembly with low-power feature
EP3071260A1 (fr) Module de capteur rotatif avec caractéristique de resynchronisation
WO2017148855A1 (fr) Agencement de commutation pour dispositif d'administration de médicament à capture de données
JP2019536573A (ja) ペアリング機能を備える付属デバイス
US20170292859A1 (en) Rotary Sensor Component and Method of Manufacture

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150921

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160613

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WINDUM, JESPER PETER

Inventor name: MADSEN, JOHN OESTERGAARD

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 849224

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014005212

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20161130

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 849224

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170228

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170301

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170228

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170330

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170228

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014005212

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20170831

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170219

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170219

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170219

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140219

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161130

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170330

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240123

Year of fee payment: 11

Ref country code: CH

Payment date: 20240301

Year of fee payment: 11

Ref country code: GB

Payment date: 20240123

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240123

Year of fee payment: 11